Impact of CYP3A4 functional variability on ziprasidone metabolism
IntroductionZiprasidone is primarily metabolized by CYP3A4, an enzyme with genetic variability and susceptibility to inhibition or induction. This study explored the functional variability of CYP3A4 in ziprasidone metabolism, focusing on drug interactions and genetic polymorphisms.MethodsThe metabol...
Saved in:
| Main Authors: | Qi Zhou, Yameng Wu, Zhize Ye, Zheyan Zhang, Kai Zheng, Jianchang Qian, Zhongxiang Xiao, Yang Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1585040/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valproic acid levels in neurodevelopmental disorders: correlation with CYP and SULT genes using LC-MS/MS
by: Shada Abutaleb, et al.
Published: (2025-03-01) -
LC-MS/MS-Based Concurrent Quantification of Cannabidiol and Melatonin in Mouse Plasma to Elucidate Complex PK Interactions
by: Mengran Wang, et al.
Published: (2024-11-01) -
Ziprasidone Hydrochloride Nanosuspension for Bioavailability Enhancement: Design, Development and Evaluation
by: Paun Jalpa S., et al.
Published: (2025-01-01) -
CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms
by: Yuqing Zhang, et al.
Published: (2024-12-01) -
Inhibitory effect of carvedilol on bedaquiline metabolism in vitro and in vivo
by: Qingqing Li, et al.
Published: (2025-04-01)